Flexion Therapeutics CEO and leadership

Mike Clayman is a Board Member at FLEXION THERAPEUTICS INC, Chairman at Ribometrix Inc, and CEO at FLEXION THERAPEUTICS INC and is based in Durham, North Carolina. He has worked as VP, R and D at ACS; Vice President at Lilly Research Labs; and Vice President, Lilly Research Laboratories at ELI LILLY & CO. Michael works or has worked as CHAIRMAN at Lilly's Bioethics Committee, Assistant Professor at University of Pennsylvania, and Assistant Professor at Trustees of the University of Pennsylvania/The. He studied at University Of California San Diego School Of Medicine between 1974 and 1978 and Yale between 1970 and 1974.

Dr. Neil Bodick C. is a Chief Medical Officer at FLEXION THERAPEUTICS INC and is based in United States.

Christina Willwerth is a Chief Strategy Officer at FLEXION THERAPEUTICS INC and VP:Clinical Operations at FLEXION THERAPEUTICS INC and is based in Greater Boston. She has worked as Vice President, Product Development at PERKINELMER INC; Clinical Research Associate II at Biopure; and Senior VP:Program Management at FLEXION THERAPEUTICS INC. Christina works or has worked at Viacell Inc and Pbbpc Inc and works or has worked as VP:Product Development at Viacell Inc. She studied at Worcester Polytechnic Institute (WPI) between 1989 and 1992.

25+ years of persistent forecast achievement; responsible for 4 product launches & 2 line extensions at the leadership level; repeated experience in branding, commercialization, strategic marketing, sales leadership, market access function construction/leadership in mass/specialty/orphan markets; experience with oral small molecule, injectable & radiopharmaceutical products as well as diagnostic imaging agents working with gov’t and commercial payers across hospital and non-hospital care settings, inclusive of buy & bill and specialty distribution models; significant experience in establishing and maintaining coding, coverage & payment across product types; have built markets, created demand, taken and maintained market leadership; have developed and lead successful execution of lifecycle management strategy including label expansion and next generation product development in exclusive and competitive markets.

Clinical discipline experience in Cardiology/Cardiovascular, CNS/Neuro/Psychology, Gastroenterology, Gynecology, Oncology, Pulmonology/Respiratory & Urology

Repeated experience in building & retaining strong teams, consensus-building, change management; highly skilled in data collection, analysis and configuration, connecting seemingly disparate bits of information to form or inform strategy & optimize execution

Successful cross functional collaboration experience with R&D, BD, IR, Medical Affairs, Legal & Regulatory, pursuant to clinical/PE publications, product label expansion, patent protection, compliant & innovative promotional programming, lifecycle management, external asset assessment/acquisition and international expansion

International experience with personal in-country management as well as global/regional partner models in EU, Australia, Asia/Pac.

Sales/management experience from representative through local/regional management to VP, sales force sizes ranging from 80 to 1000

Exceedingly strong written, verbal and presentation skills spanning internal, customer, executive and public markets audiences

Mike Clayman is a Board Member at FLEXION THERAPEUTICS INC, Chairman at Ribometrix Inc, and CEO at FLEXION THERAPEUTICS INC and is based in Durham, North Carolina. He has worked as VP, R and D at ACS; Vice President at Lilly Research Labs; and Vice President, Lilly Research Laboratories at ELI LILLY & CO. Michael works or has worked as CHAIRMAN at Lilly's Bioethics Committee, Assistant Professor at University of Pennsylvania, and Assistant Professor at Trustees of the University of Pennsylvania/The. He studied at University Of California San Diego School Of Medicine between 1974 and 1978 and Yale between 1970 and 1974.

Dr. Neil Bodick C. is a Chief Medical Officer at FLEXION THERAPEUTICS INC and is based in United States.

Mike Clayman is a Board Member at FLEXION THERAPEUTICS INC, Chairman at Ribometrix Inc, and CEO at FLEXION THERAPEUTICS INC and is based in Durham, North Carolina. He has worked as VP, R and D at ACS; Vice President at Lilly Research Labs; and Vice President, Lilly Research Laboratories at ELI LILLY & CO. Michael works or has worked as CHAIRMAN at Lilly's Bioethics Committee, Assistant Professor at University of Pennsylvania, and Assistant Professor at Trustees of the University of Pennsylvania/The. He studied at University Of California San Diego School Of Medicine between 1974 and 1978 and Yale between 1970 and 1974.